Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Management Tracks

February 24, 2017 11:54 PM UTC

Celgene Corp. (NASDAQ:CELG) said President and COO Jacqualyn Fouse will retire on June 30. Scott Smith will succeed Fouse effective April 1. He is president of global inflammation and immunology. Terrie Curran will be promoted to president of global inflammation and immunology from head of worldwide commercial markets for inflammation and immunology.

Epigenetics company Storm Therapeutics Ltd. (Cambridge, U.K.) named Keith Blundy CEO. He was CEO at Cancer Research Technology Ltd. (London, U.K.)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article